Immunological aspects of antitumor photodynamic therapy outcome

Central European Journal of Immunology

Volumn 40, Issue 4, 2015, Pages 481-485

  Wachowska, Malgorzata ^a   Muchowicz, Angelika ^b   Demkow, Urszula ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Antitumor immunity; Cancer; Photodynamic therapy

Indexed keywords

ARACHIDONIC ACID; BIOLOGICAL FACTOR; DAMAGE ASSOCIATED MOLECULAR PATTERN; INTERLEUKIN 1BETA; PATTERN RECOGNITION RECEPTOR; PHOTOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ADAPTIVE IMMUNITY; ARTICLE; BASEMENT MEMBRANE; CANCER THERAPY; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; LIPID PEROXIDATION; MACROPHAGE; MAST CELL; MEMBRANE DAMAGE; MONOCYTE; NATURAL KILLER CELL; NEOPLASM; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTOSIS; PHOTODYNAMIC THERAPY; TUMOR IMMUNITY;

EID: 84983195615     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: 10.5114/ceji.2015.56974     Document Type: Article

References (29)

1. Agostinis P, Berg K, Cengel KA, et al. (2011): Photodynamic therapy of cancer: an update. CA Cancer J Clin 4: 250-281.
2. van Duijnhoven FH, Aalbers RI, Rovers JP, et al. (2003): The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiology 2: 105-113.
3. Nowis D, Makowski M, Stokłosa T, et al. (2005): Direct tumor damage mechanisms of photodynamic therapy. Acta Biochim Pol 2: 339-352.
4. Korbelik M (2006): PDT-associated host response and its role in the therapy outcome. Lasers Surg Med 5: 500-508.
5. Korbelik M, Dougherty GJ (1999): Photodynamic thera-py-mediated immune response against subcutaneous mouse tumors. Cancer Res 8: 1941-1946.
6. Dolmans DE, Fukumura D, Jain RK (2003): Photodynamic therapy for cancer. Nat Rev Cancer 5: 380-387.
7. Kick G, Messer G, Goetz A, et al. (1995): Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kappa B DNA binding. Cancer Res 11: 2373-2379.
8. Krosl G, Korbelik M, Krosl J, Dougherty GJ (1996): Poten-tiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor. Cancer Res 14: 3281-3286.
9. Canti G, De Simone A, Korbelik M (2002): Photodynamic therapy and the immune system in experimental oncology. Photochem Photobiol Sci 1: 79-80.
10. Belicha-Villanueva A, Riddell J, Bangia N, Gollnick SO (2012): The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related molecules. Lasers Surg Med 1: 60-68.
11. Firczuk M, Nowis D, Golab J (2011): PDT-induced inflam-matory and host responses. Photochem Photobiol Sci 5: 653-663.
12. Krysko DV, Agostinis P, Krysko O, et al. (2011): Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 4: 157-164.
13. Garg AD, Nowis D, Golab J, et al. (2010): Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochim Biophys Acta 1: 53-71.
14. Wachowska M, Gabrysiak M, Muchowicz A, et al. (2014): 5-Aza-2'-deoxycytidine potentiates antitumour immune re-sponse induced by photodynamic therapy. Eur J Cancer 7: 1370-1381.
15. Gollnick SO, Brackett CM (2010): Enhancement of anti-tu-mor immunity by photodynamic therapy. Immunol Res 1-3: 216-226.
16. Jalili A, Makowski M, Switaj T, et al. (2004): Effective pho-toimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clin Cancer Res 13: 4498-4508.
17. Korbelik M, Krosl G, Krosl J, et al. (1996): The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Res 24: 5647-5652.
18. Castano AP, Mroz P, Hamblin MR (2006): Photodynamic ther-apy and anti-tumour immunity. Nat Rev Cancer 7: 535-545.
19. Thong PS, Ong KW, Goh NS, et al. (2007): Photodynam-ic-therapy-activated immune response against distant untreated tumours in recurrent angiosarcoma. Lancet Oncol 10: 950-952.
20. Mroz P, Hamblin MR (2011): The immunosuppressive side of PDT. Photochem Photobiol Sci 5: 751-758.
21. Elmets CA, Bowen KD (1986): Immunological suppression in mice treated with hematoporphyrin derivative photoradiation. Cancer Res 4 Pt 1: 1608-1611.
22. Lynch DH, Haddad S, King VJ, et al. (1989): Systemic im-munosuppression induced by photodynamic therapy (PDT) is adoptively transferred by macrophages. Photochem Photobiol 4: 453-458.
23. Griffith TS, Kazama H, VanOosten RL, et al. (2007): Apop-totic cells induce tolerance by generating helpless CD8+ T cells that produce TRAIL. J Immunol 5: 2679-2687.
24. Reginato E, Mroz P, Chung H, et al. (2013): Photodynamic therapy plus regulatory T-cell depletion produces immunity against a mouse tumour that expresses a self-antigen. Br J Cancer 8: 2167-2174.
25. Kazama H, Ricci JE, Herndon JM, et al. (2008): Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 1: 21-32.
26. Laxmanan S, Robertson SW, Wang E, et al. (2005): Vascular endothelial growth factor impairs the functional ability of dendritic cells through Id pathways. Biochem Biophys Res Commun 1: 193-198.
27. Golab J, Wilczynski G, Zagozdzon R, et al. (2000): Poten-tiation of the anti-tumour effects of Photofrin-based pho-todynamic therapy by localized treatment with G-CSF. Br J Cancer 8: 1485-1491.
28. Bellnier DA (1991): Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factor-alpha. J Photochem Photobiol B 2: 203-210.
29. Wachowska M, Gabrysiak M, Muchowicz A, et al. (2014): 5-Aza-2'-deoxycytidine potentiates antitumour immune re-sponse induced by photodynamic therapy. Eur J Cancer 2014; 50: 1370-1381.